Tag: Cancer: Misc.
COVID-19 Case Fatality Rate Increased for Cancer Patients
Case fatality rates were 37 and 25 percent for hematologic and solid malignancies, respectively
PFS Prolonged With Continuous Dabrafenib, Trametinib in Melanoma
Median PFS longer with continuous versus intermittent treatment, but overall survival similar
Multicancer Blood Test, PET-CT Combo Feasible for Cancer Screen
One percent of participants underwent PET-CT imaging due to false-positive blood tests
Pediatric Brain Cancer Outcomes Worse for Black, Hispanic Patients
Disparities for disease severity not seen at diagnosis, meaning postdiagnosis factors may affect outcome
Infection Rate Up Prior to Detection of Malignant Cancer
Increased odds of influenza, gastroenteritis, hepatitis, pneumonia seen one year before detection
Racial Differences Seen for Cancer Diagnosis, Treatment, Survival
White, black, and Hispanic patients have worse odds of cancer-specific and overall survival versus Asian patients
Burden of Childhood Cancer Can Be Diminished
Comprehensive scale-up of interventions could avert 6.2 million deaths in children with cancer
March 2020 Briefing – Hematology & Oncology
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for March 2020. This roundup includes...
Methylation Analysis of cfDNA IDs >50 Cancer Types
Sensitivity increased with increasing stage from 39 percent in stage I to 92 percent in stage IV
Increased Risk for SARS-CoV-2 Seen in Cancer Patients in Wuhan
Of the 12 patients with COVID-19, six developed severe acute respiratory syndrome; three died
